Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Dental Research
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Orozco, A.
Right arrow Articles by Seymour, G.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orozco, A.
Right arrow Articles by Seymour, G.J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Interleukin 18 and Periodontal Disease

A. Orozco1,*, E. Gemmell1, M. Bickel1 and G.J. Seymour2

1 School of Dentistry, Turbot Street, Brisbane 4000, Australia; and
2 Faculty of Dentistry, University of Otago, Dunedin, New Zealand


Figure 1
View larger version (56K):
[in this window]
[in a new window]

 
Figure 1. Signal transduction pathways of IL-18. Intracellular activation of caspase (caspase-1 or caspase-1-like enzymes) in antigen-presenting cells is mediated through Toll-like receptor (TLR) or Fas signaling, respectively. Caspase-1 and the extracellular serine esterase PR-3 induce activation of biologically active interleukin (IL)-18 (18 kDa) by cleavage of its precursor, pro-IL-18 (24 kDa). If not inactivated by the extracellular IL-18-binding protein (IL-18BP), processed mature IL-18 mediates IL-18RC aggregation (IL-18 receptor complex, consisting of IL-18R{alpha}l, IL-18, CD48, and GPI), which binds to IL-18Rβ, leading to signal transduction by recruiting myeloid differentiation factor (MyD88), as well as IL-1 receptor-associated kinase (IRAK) in the effector cell. After phosphorylation, IRAK dissociates from the receptor complex and associates with tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6), which then leads to sequential activation of NF- {kappa}B binding kinase (NIK), I-{kappa}B kinases (IKK-1, IKK-2), and NF-{kappa}B. Alternatively, the binding of IL-18 triggers the activation of Ras via a src family member of tyrosine kinases, the lymphocyte-specific tyrosine-specific protein kinase of 56 kDa (p56lck). Ras then sequentially activates Raf, mitogen-activated extracellular signal-regulated kinase-activating kinase (MEK) and mitogen-activated protein kinase (MAPK). This induces phosphorylation of MAPK, which is then translocated into the nucleus and phosphorylates CCAAT/enhancer-binding protein (C/EBP), enabling it to associate with the C/EBP binding site. Both NF-{kappa}B and C/EBP induce gene transcription to produce further inflammatory mediators (such as IFN-{gamma}, TNF-{alpha}, IL-6, etc.). Adapted and modified from Tschoeke et al.(2006) and Fukushima et al.(2005).

 

Figure 2
View larger version (49K):
[in this window]
[in a new window]

 
Figure 2. IL-18 roles in adaptive and innate immunity. IL-18 is produced by several cells from the innate and adaptive immune systems, on stimulation by LPS, FasL, or interferons. The target cells of IL-18 include innate as well as adaptive immune cells. IL-18 exerts a synergistic effect with IL-12. IL-18 signals through a heterodimeric receptor, which recruits MyD88 and leads to the activation of the NF-{kappa}B and AP-1 transcription factors (left inset). IL-18 signaling drives (top inset) the transcription of a set of cytokines (IFN-{gamma}, TNF, IL-4, IL-6, IL-8), growth factors (GM-CSF]), and enzymes (NOS, COX-2, MMP3). However, IFN-{gamma} is considered to be the key molecule induced by IL-18. MØ, macrophages; DC, dendritic cells; NOS, NO synthase; COX2, cyclo-oxygenase 2; MMP3, stromelysin; TIR, Toll/IL-1R domain; IL-18BP, IL-18-binding protein; IRAK, IL-1 receptor–associated kinase; TRAF6, TNF receptor–associated factor 6; IL-18R{alpha},β, {alpha} and β chains of IL-18 receptor. Adapted and modified from Caligiuri et al.(2005).

 

Journal of Dental Research, Vol. 86, No. 7, 586-593 (2007)
DOI: 10.1177/154405910708600702


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?